Principal Financial Group cut its stake in Nu Skin Enterprises (NYSE:NUS – Free Report) by 1.9% during the first quarter, according to its latest 13F filing with the SEC. The company held 306,912 shares after selling 5,903 shares during the quarter. Principal Financial Group held about 0.62% of Nu Skin Enterprises, valued at $12.065 million, at the end of the most recent quarter.
Many other institutional investors have also recently bought and sold shares. State Street Corp. increased its stake in Nu Skin Enterprises by 3.3% in the third quarter. State Street Corporation acquired an additional 305,539 shares during the period and now owns 9,466,774 shares in the company, valued at $315.906 million. BlackRock increased its stake in Nu Skin Enterprises by 0.5% in the first quarter. BlackRock Inc. acquired an additional 30,340 shares during the period, and he now owns 5,791,181 shares of the company worth $277,281,000. Renaissance Technologies LLC increased its Nu Skin Enterprises stake by 2.2% in the first quarter. Renaissance Technologies LLC acquired an additional 58,600 of his shares during the period and now owns 2,670,996 shares of the company stock valued at $127,887,000. Dimensional Fund Advisors LP increased its holding in Nu Skin Enterprises by 5.2% during the fourth quarter. Dimensional Fund Advisors LP acquired an additional 100,543 shares during the period and now owns 2,016,407 shares of the company at a value of $8,5012,000. Finally, Millennium Management LLC increased its stake in Nu Skin Enterprises by 5,827.8% during the fourth quarter. Millennium Management LLC acquired an additional 958,725 shares during the period and now owns 975,176 shares of the company stock valued at $4,1113,000. 89.06% of the shares are held by institutional investors.
Nu Skin Enterprises up 1.9%
NUS opened at $23.76 on Monday. The company has a market cap of $1.19 billion, a P/E ratio of 16.85 and a beta of 1.17. Nu Skin Enterprises hit a 12-month low of $23.00 and a 12-month high of $45.55. The company’s current ratio is 1.78x, quick ratio is 0.94x, and debt-to-equity ratio is 0.41x. The stock has a 50-day moving average of $28.87 and a 200-day moving average of $35.35.
Nu Skin Enterprises (NYSE:NUS – Get Your Free Report) last reported quarterly results on Tuesday, August 1. The company reported EPS of $0.54 for the quarter, beating consensus expectations of $0.53 by $0.01. The company’s revenue for the quarter was $502.6 million, compared with analyst expectations of $512.35 million. Nu Skin Enterprises had a return on equity of 12.88% and a net profit margin of 3.43%. Research analysts forecast Nu Skin Enterprises’ EPS for the current year to be his 2.47 for the group as a whole.
Nu Skin Enterprises Announces Dividend
The company also recently announced a quarterly dividend to be paid on Wednesday, September 6. The shareholder of record on Friday, August 25 will be paid a dividend of $0.39 per share. The ex-dividend date for this dividend will be August 24 (Thursday). This equates to his $1.56 dividend and his 6.57% dividend yield on an annualized basis. Nu Skin Enterprises payout ratio is 110.64%.
Wall Street analyst speaks out
Many equity research analysts have commented on NUS shares. DA Davidson said in a report Thursday, Aug. 3, that Nu Skin lowered his Enterprise price target from $38.00 to $29.00 and set the stock valuation to “neutral.” StockNews.com began covering Nu Skin Enterprises in an investigative report on Thursday, August 17th. They set a “Hold” rating on the company. Finally, Stifel Nicolaus lowered Nu Skin Enterprises’ target price from his $43.00 to his $35.00, setting the company’s rating to “Hold” in a research report on Wednesday, Aug. 2. Five investment analysts have a Hold rating on the stock, according to Marketbeat data. Nu Skin Enterprises currently has a consensus rating of “hold” and a consensus price target of $36.00, according to Marketbeat data.
Get the latest report on Nu Skin Enterprise
Insider activity
In other news, director Andrew D. Lippman sold 2,000 shares of the company in a transaction that took place on Monday, June 26th. The stock sold at an average price of $32.12, giving him a trading value of $64,240.00. After the transaction, the directors now own 60,625 shares of the company, valued at $1,947,275. The deal was disclosed in his SEC legal filings, which are available at this link. In related news, director Andrew D. Lippman sold 2,000 shares of the company in a transaction that took place on Monday, June 26th. The shares sold at an average price of $32.12, giving him a total of $64,240.00. After the sale was completed, the directors owned 60,625 shares of the company, valued at $1,947,275. The sale was disclosed in documents filed with the Securities and Exchange Commission, which can be accessed on the SEC’s website. Director Laura Nathanson also sold 6,068 shares in the company in a transaction that took place on Monday, August 21. The shares were sold at an average price of $24.12 for a total of $146,360.16. After the sale was completed, the directors owned 10,300 shares of the company, valued at approximately $248,436. Disclosure information regarding this sale can be found here. In the past 90 days, insiders sold 11,340 shares of the company, worth $301,843. His 2.00% of shares are now owned by insiders.
About Nu Skin Enterprises
(free report)
Nu Skin Enterprises, Inc, along with its subsidiaries, develops and markets a wide range of beauty and wellness products worldwide. We provide skin care equipment such as ageLOC LumiSpa, ageLOC LumiSpa iO, ageLOC Body Spa, cosmetics and other personal care products. Nourishing skin care product.
References
This instant news alert was generated by MarketBeat’s narrative science technology and financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments regarding this story to contact@marketbeat.com.
Before you consider Nu Skin Enterprises, listen to this.
MarketBeat tracks Wall Street’s highest-rated, highest-performing research analysts and the stocks they recommend to clients every day. Nu Skin Enterprises wasn’t on the list, Marketbeat identified five stocks top analysts are secretly whispering to customers to buy now before the whole market goes viral.
Nu Skin Enterprises currently has a Hold rating among analysts, but high-scoring analysts think these five stocks are better buys.
Click here for 5 brands
What stocks are major institutional investors such as hedge funds and endowments buying in today’s market? Clicking the link below will send you a list of his 13 stocks on MarketBeat that institutional investors are buying up ASAP.
Get This Free Report
https://www.marketbeat.com/instant-alerts/nyse-nus-sec-filing-2023-08-28/
